Results

Total Results: over 10,000 records

Showing results for "disorders".

  1. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-icd-codes.pdf
    June 14, 2019 - ICD-9 Codes of the Chronic Conditions Used in this Analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  2. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  3. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-icd-9codes.pdf
    May 17, 2019 - ICD-9 codes of the chronic conditions included in our analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  4. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-icd-codes.pdf
    June 14, 2019 - ICD-9 Codes of the Chronic Conditions Used in this Analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  5. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-icd-9codes.pdf
    May 17, 2019 - ICD-9 codes of the chronic conditions included in our analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  6. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-icd-9codes.pdf
    May 17, 2019 - ICD-9 codes of the chronic conditions included in our analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  7. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  8. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-icd-9codes.pdf
    May 17, 2019 - ICD-9 codes of the chronic conditions included in our analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  9. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  10. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-icd-codes.pdf
    June 14, 2019 - ICD-9 Codes of the Chronic Conditions Used in this Analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  11. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  12. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  13. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-icd-codes.pdf
    June 14, 2019 - ICD-9 Codes of the Chronic Conditions Used in this Analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  14. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-icd-9codes.pdf
    May 17, 2019 - ICD-9 codes of the chronic conditions included in our analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  15. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-icd-codes.pdf
    June 14, 2019 - ICD-9 Codes of the Chronic Conditions Used in this Analysis: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  16. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-7-b-icd-9-codes.pdf
    September 12, 2018 - conditions included in the analysis for this measure are as follows: DIABETES 250-250.91 METABOLIC DISORDERS … 270–273.9, 275-.9 270 Disorders of amino-acid transport & metabolism 271 Disorders of carbohydrate … transport & metabolism 272 Disorders of lipid metabolism 273 Disorders of plasma protein metabolism … 275 Disorders of mineral metabolism BLOOD DISORDERS 281-.9, 282-9, 283–284.9, 286–286.9, 288–288.9 … involving the immune mechanism 288.1 Functional disorders of polymorphonuclear neutrophils 288.2 Genetic
  17. hcup-us.ahrq.gov/reports/natstats/94drgb.htm
    September 01, 1997 - of pancreas 160,154 0.46 6.32 10,232 except malignancy 205 Disorders … of the 68,233 0.20 5.82 8,933 biliary tract w/ CC 208 Disorders … w/ CC 241 Connective tissue 14,980 0.04 4.31 6,029 disorders w/ … w/ CC 275 Malignant breast 999 0.00 2.94 5,335 disorders w/ … 27,848 0.08 7.06 10,357 w/ CC 301 Endocrine disorders 9,474
  18. hcup-us.ahrq.gov/reports/natstats/93drgb.htm
    September 01, 1997 - of pancreas 153,353 0.44 6.75 10,066 except malignancy 205 Disorders of … 7.51 11,983 except malignancy, cirrhosis, alcoholic hepatitis w/ CC 206 Disorders … of the 65,095 0.19 5.79 8,886 biliary tract w/ CC 208 Disorders … w/ CC 241 Connective tissue 16,853 0.05 4.50 5,838 disorders w/o … w/ CC 275 Malignant breast 1,283 0.00 4.43 6,927 disorders w/o
  19. Ff 2009 Exhibit2 5 (pdf file)

    hcup-us.ahrq.gov/reports/factsandfigures/2009/pdfs/FF_2009_exhibit2_5.pdf
    January 01, 2009 - , and other back problems 258 288 2% 2% 11% ‡ Mood disorders 227 285 2% 2% … ** 1,676 2,388 100% 100% 42% Liveborn (newborn infant) 191 218 11% 9% 15% ‡ Mood disorders …  Mood disorders was the third most common condition with Medicaid as the primary payer and grew …  Mood disorders was a frequent cause of hospitalization among the privately insured, and increased …  Mood disorders was the second most common principal diagnosis among uninsured stays, making up
  20. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-effectiveness-of-interventions-intended-to-treat-anxiety-disorders-in-children-18-years-of-age-over-the-long-term-6-12-months-what-is-the-effectiveness-of-interventions-intended-to-prevent-the-development-of-anxie
    March 07, 2013 - What is the effectiveness of interventions intended to treat anxiety disorders in children (<18 years … What is the effectiveness of interventions intended to prevent the development of anxiety disorders in … What is the effectiveness of combination interventions (pharmacologic and behavioral) for anxiety disorders … What are the harms of treatments for anxiety disorders in children? … 12-20% across disorders.